Bosch-Barrera, J.; Verdura, S.; Ruffinelli, J.C.; Carcereny, E.; Sais, E.; Cuyà s, E.; Palmero, R.; Lopez-Bonet, E.; Hernández-MartÃnez, A.; Oliveras, G.;
et al. Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer. Cancers 2021, 13, 4168.
https://doi.org/10.3390/cancers13164168
AMA Style
Bosch-Barrera J, Verdura S, Ruffinelli JC, Carcereny E, Sais E, Cuyà s E, Palmero R, Lopez-Bonet E, Hernández-MartÃnez A, Oliveras G,
et al. Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer. Cancers. 2021; 13(16):4168.
https://doi.org/10.3390/cancers13164168
Chicago/Turabian Style
Bosch-Barrera, Joaquim, Sara Verdura, José Carlos Ruffinelli, Enric Carcereny, Elia Sais, Elisabet Cuyà s, Ramon Palmero, Eugeni Lopez-Bonet, Alejandro Hernández-MartÃnez, Gloria Oliveras,
and et al. 2021. "Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer" Cancers 13, no. 16: 4168.
https://doi.org/10.3390/cancers13164168
APA Style
Bosch-Barrera, J., Verdura, S., Ruffinelli, J. C., Carcereny, E., Sais, E., Cuyà s, E., Palmero, R., Lopez-Bonet, E., Hernández-MartÃnez, A., Oliveras, G., Buxó, M., Izquierdo, A., Morán, T., Nadal, E., & Menendez, J. A.
(2021). Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer. Cancers, 13(16), 4168.
https://doi.org/10.3390/cancers13164168
